Low-dose IL-2 as a therapeutic agent for tolerance induction

被引：0
|
作者：
Malek, Thomas R. [1 ,2 ]
Pugliese, Alberto [1 ,2 ,3 ]
机构：
[1] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33101 USA
[2] Univ Miami, Miller Sch Med, Diabet Res Inst, Miami, FL 33101 USA
[3] Univ Miami, Miller Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Miami, FL 33101 USA
来源：
IMMUNOTHERAPY | 2011年 / 3卷 / 11期
关键词：
IL-2; tolerance; T regulatory cells; Type; 1; diabetes; REGULATORY T-CELLS; INTERLEUKIN-2; PRODUCTION; DIABETES-MELLITUS; COMPLEXES; EXPANSION; IMMUNITY;
D O I：
10.2217/IMT.11.120
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1281 / 1284
页数：4
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF LOW-DOSE IL-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Su, Q. Y.
    Luo, J.
    Di, J. K.
    Yin, X. Y.
    Xu, D. N.
    Li, X.
    Wang, C.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 640 - 641
  • [32] LOW-DOSE IL-2 RESTORES TREG-MEDIATED IMMUNE TOLERANCE IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS
    Wu, R.
    Su, R.
    Ding, T.
    Xue, H.
    An, J.
    Jiang, L.
    Li, X. F.
    Wang, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1079 - 1080
  • [33] HLA-Restriction of Human Treg Cells Is Not Required for Therapeutic Efficacy of Low-Dose IL-2 in Humanized Mice
    Tyagi, Rajeev K.
    Jacobse, Justin
    Li, Jing
    Allaman, Margret M.
    Otipoby, Kevin L.
    Sampson, Erik R.
    Wilson, Keith T.
    Goettel, Jeremy A.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [34] Endogenous IL-33 contributes to Treg expansion induced by IL-2/CD25, a novel IL-2 biologic developed for low-dose IL-2 therapy
    Lui, Jen Bon P.
    Malek, Thomas R.
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [35] Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells
    Akimichi Inaba
    Zewen Kelvin Tuong
    Tian X. Zhao
    Andrew P. Stewart
    Rebeccah Mathews
    Lucy Truman
    Rouchelle Sriranjan
    Jane Kennet
    Kourosh Saeb-Parsy
    Linda Wicker
    Frank Waldron-Lynch
    Joseph Cheriyan
    John A. Todd
    Ziad Mallat
    Menna R. Clatworthy
    Nature Communications, 14
  • [36] Low-dose IL-2 enhances the generation of IL-10-producing immunoregulatory B cells
    Inaba, Akimichi
    Tuong, Zewen Kelvin
    Zhao, Tian X. X.
    Stewart, Andrew P. P.
    Mathews, Rebeccah
    Truman, Lucy
    Sriranjan, Rouchelle
    Kennet, Jane
    Saeb-Parsy, Kourosh
    Wicker, Linda
    Waldron-Lynch, Frank
    Cheriyan, Joseph
    Todd, John A. A.
    Mallat, Ziad
    Clatworthy, Menna R. R.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [37] During aGVHD low-dose IL-2 activates allogeneic T cells and fails to induce Treg-mediated tolerance
    Perol, L.
    Martin, G. H.
    Cohen, J. L.
    Piaggio, E.
    IMMUNOLOGY, 2012, 137 : 740 - 740
  • [38] Low-dose IL-2 therapy expands human regulatory T cell populations
    Nature Reviews Immunology, 2012, 12 (1) : 6 - 6
  • [39] Pharmacodynamics of regulatory T cells in mice and humans treated with low-dose IL-2
    Churlaud, Guillaume
    Abbara, Chadi
    Vinot, Pierre-Axel
    Fourcade, Gwladys
    Ritvo, Paul-Gydeon
    Lorenzon, Roberta
    Rosenzwajg, Michelle
    Diquet, Bertrand
    Klatzmann, David
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (04) : 1344 - 1346
  • [40] The Effect of Low-Dose IL-2 in Clinical Facial Transplantation: Molecular and Immunological Response
    Murakami, N.
    Win, T.
    Borges, T.
    Lian, C.
    Murphy, G.
    Bueno, E.
    Clark, R.
    Strom, T.
    Pomahac, B.
    Riella, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 610 - 611
12345